Koronis Pharmaceuticals
Latest round
- Series E
Last raised
- Mar 2009
Total raised
- $20M
Investors
- 2
About Koronis Pharmaceuticals
Koronis Pharmaceuticals, Inc.Founded in 1998, Koronis Pharmaceuticals, Inc. is headquartered in Seattle, US. The company specializes in antiviral treatments and has undergone strategic pivots to enhance its research capabilities.Koronis Pharmaceuticals, Inc. specializes in the development of antiviral technologies aimed at chronic viral diseases, particularly HIV, HBV, and HCV. The company's primary product candidate, KP-1461, utilizes a novel therapeutic mechanism known as Viral Decay Acceleration™ (VDA) to promote viral mutation leading to viral collapse. In addition, Koronis has created Stealth Nucleosides™, which leverage viral mutagenesis to harness the inherent high mutation rate of various viruses.Koronis Pharmaceuticals generates revenue through partnerships with research institutions and pharmaceutical companies, primarily from clinical trials and technology licensing. Its key product, KP-1461, is currently undergoing clinical trials for HIV treatment, which could facilitate revenue generation upon successful commercialization through sponsorship agreements, licensing fees, and milestone payments.Koronis Pharmaceuticals plans to advance its product pipeline, specifically focusing on KP-1461 and additional antiviral treatments, aiming for new product launches within the next few years. The company is also targeting expansion into European markets to broaden its reach by 2025.06 mn will be utilized to support these growth initiatives, enhancing development efforts and expanding partnerships.
Who invested in Koronis Pharmaceuticals
2 investors across 2 rounds
See all investors in Koronis Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Koronis Pharmaceuticals
Who invested in Koronis Pharmaceuticals?
Koronis Pharmaceuticals has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Koronis Pharmaceuticals raised?
Koronis Pharmaceuticals has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Koronis Pharmaceuticals last raise money?
Koronis Pharmaceuticals's most recent round on record is a Series E, in Mar 2009.
What does Koronis Pharmaceuticals do?
Koronis Pharmaceuticals is a biotechnology company.
Where is Koronis Pharmaceuticals headquartered?
Koronis Pharmaceuticals is headquartered in Seattle, US.
Which VCs invest in companies like Koronis Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Koronis Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series E
Raising like Koronis Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.